Medications
Pfizer buying two meningitis vaccines from Glaxo for $130M
Pfizer will buy two meningitis vaccines from GlaxoSmithKline in a deal that the U.S. drugmaker valued at about $130 million.
Jun 22, 2015
0
3
News tagged with novartis ag
Other
Swiss drug maker Novartis posts Q4 profit drop
Swiss pharmaceutical giant Novartis AG says fourth quarter net income dropped 26 percent but the company still posted a healthy 2014 annual profit.
Jan 27, 2015
0
5
Medications
Novartis to close manufacturing plant in Puerto Rico by 2019
Novartis AG is closing its manufacturing plant in Puerto Rico as part of a major overhaul of its business, the company said in a statement Friday.
Jan 16, 2015
0
9
Medications
European drug regulator: Novartis flu vaccine OK
Europe's drug regulator says there is no proof that a flu vaccine for the elderly was linked to side effects, including deaths in Italy.
Dec 3, 2014
0
0
Medications
Novartis selling flu vaccine unit to CSL for $275M
Australian drugmaker CSL Ltd. said Monday it will buy Novartis' flu vaccine business for $275 million.
Oct 27, 2014
0
0
Other
EU OKs Eli Lilly's $5.4B bid for Novartis division
The European Union's antitrust authority says it has approved the $5.4 billion sale of Novartis' animal health division to U.S. pharmaceutical firm Eli Lilly.
Oct 3, 2014
0
0
Other
Novartis cites momentum in three percent profit rise
Swiss pharmaceutical company Novartis AG posted a 3 percent rise in second-quarter profits Thursday, reflecting what it described as solid growth and an increased focus on core products.
Jul 17, 2014
0
0
Other
New drug sales help boost Novartis Q1 profit (Update)
Strong new drug sales and higher operating income helped Swiss pharmaceutical firm Novartis AG report a 24 percent rise in first-quarter profit.
Apr 24, 2014
0
0
Medications
Novartis reshapes business with GSK, Lilly deals (Update)
Swiss pharmaceutical firm Novartis AG launched a major overhaul of its business Tuesday, unveiling a series of multibillion-dollar deals with Britain's GlaxoSmithKline PLC and the U.S.'s Eli Lilly & Co. that heralds more ...
Apr 22, 2014
0
0
Other
Swiss pharma Novartis ups full-year sales outlook (Update)
Swiss pharmaceutical giant Novartis AG raised its full-year sales outlook because of delays in generic competition to its blockbuster blood pressure drug Diovan, even though it said negative currency trends contributed to ...
Oct 22, 2013
0
0
